Seattle, WA (PRWEB) April 11, 2013
The latest news out of Washington continued to show positive job growth in the economic sector. While the nation's economy continues to improve, many companies are turning to intermediary employment agencies to transition workers from part time and temporary positions into full time employees; up to as much as a third, since the beginning of the year. (challengergray.com, 4/4/13)
Though the unemployment rate steadily declined and consumer confidence has begun to resurge, according to the New York Times, President Obama has agreed to back federal funding, as well as secured private investment, for a biotechnology research project which is expected to revolutionize the field of neuroscience. The endeavor will combine the efforts of three government agencies, the National Institutes of Health, the Defense Advanced Research Projects Agency and the National Science Foundation, as well as other private institutions, to refocus efforts on research specific to the human brain, in an initiative officially called "Brain Research through Advancing Innovative Neurotechnologies" (B.R.A.I.N.).
Some skeptics in the field are concerned it is too early to determine whether the current technologies can keep pace with the projected goals. There are those within the administration who likened the scope of the attempt to the Human Genome Project. (nytimes.com, 4/2/13)
"Historically, it's been a positive move for the overall economy to invest in a solid initiative which excites people and sparks the imagination. At the same time, finding a niche that has a realistic potential for developing new technologies, creating new jobs, as well as getting the public and the private sector working together toward a common good. This has all of those elements. The project itself is very interesting and is something that, even with a moderate amount of success, could do a great deal of good for the nation in a lot of areas. That in itself is something to get excited about!" said Del Johnston, Manager of Client Relations at MedZilla.com.
Experts feel that the plan could lead to the development of new technologies and treatments for diseases like Alzheimer's, epilepsy as well as some traumatic brain injuries. According to the Times' report, supporters feel that the impact of the initiative will have nationwide significance not seen since the government's investment in science and technology research after the Russian launch of the Sputnik satellite. (nytimes.com, 4/2/13)
Experts say that the partnership between the public and private sectors is the perfect combination to get the ball rolling. Already more private institutions are becoming interested in providing computational biology laboratory space, new staff and faculty positions.
One of the research supporters, the Max Planck Florida Institute for Neuroscience's scientific director, CEO, and former professor of neurobiology at the Duke University School of Medicine, Dr. David Fitzpatrick released a statement, "In the last five years, we've only just cracked open the door to technologies that make the impossible finally possible. You can't fix it if you don't know how it works. If we can't get to this detailed level of understanding of brain organization and activity, then we're not going to be in a position to effectively address brain disorders." (fiercebiotechresearch.com, 4/5/13)
John Burkhardt Managing Director of MedZilla.com noted: "This definitely has the potential for some exciting advances as well as another area of job growth in the research and biotechnology job sectors, as well as some other related fields. However, more than that, it’s great to see both public and private investors willing to work together to make that investment."
Established in mid-1994, MedZilla is the original and leading web site to serve career and hiring needs for professionals and employers in biotechnology, pharmaceuticals, medicine, science and healthcare. The MedZilla jobs database contains about 7,500 open positions. The resume database currently contains over 295,000 resumes with 26,500 less than three months old. These resources have been characterized as the largest, most comprehensive databases of their kind on the web in the industries served.
MedZilla(R) is a Registered Trademark owned by MedZilla Inc. Copyright (C)MedZilla, Inc. Permission is granted to reproduce and distribute this text in its entirety, and if electronically, with a link to the URL http://www.medzilla.com. For permission to quote from or reproduce any portion of this message, please contact MedZilla, Inc. at press(at)medzilla(dot)com
Contact: MedZilla, Inc.
Phone: (360) 657-5681